Original ArticleA Phase II Study of Tg4010 (Mva-Muc1-Il2) in Association with Chemotherapy in Patients with Stage III/IV Non-small Cell Lung Cancer
Under an Elsevier user license
open archive
Key Words
Phase II study
Recombinant viral vector
Chemotherapy
Non-small cell lung cancer
Vaccine
MUC1
MVA
Cited by (0)
Disclosure: The authors declare no conflict of interest.
Copyright © 2008 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.